adenosine monophosphate has been researched along with Thrombocytopenia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (68.75) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Alberio, L; Iafrate, M; Kirsch, M; Marcucci, C; Pantet, O; Pitta-Gros, B; Scala, E | 1 |
| Henderson, R; Tanaka, KA; Williams, B | 1 |
| Banks, DA; Girgis, AM | 1 |
| Auger, WR; Forfia, PR; Mishra, S; Morewood, GH; Salamanca-Padilla, YY; Ta, J; Toyoda, Y; Vaidya, A | 1 |
| Geube, M; Sale, S | 1 |
| Demirkan, K; Yalçın, N | 1 |
| Angiolillo, DJ; Bhatt, DL; Deliargyris, EN; Gibson, CM; Groves, EM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD | 1 |
| Curzen, N; Mamas, MA | 1 |
| Gernhofer, YK; Khoche, S; Pretorius, V; Ross, M | 1 |
| Maus, T; Pretorius, V; Ross, M; Seider, S | 1 |
| Boyle, AJ; Danelich, IM; Entwistle, JW; Kabadi, RA; Marhefka, GD; Qureshi, AM; Reeves, G | 1 |
| Banks, DA; Girgis, AM; Golts, E; Humber, D | 1 |
| Erdoes, G; Koster, A; Reid, C | 1 |
| Blazejczyk, A; Kalchenko, V; Przygodzki, T; Talar, M; Watala, C | 1 |
| Bernheim, J; Bryon, PA; Colon, S; Dechavanne, M; Lagarde, M; Pozet, N; Traeger, J | 1 |
| Chernesky, MA; Larke, RP; Mustard, JF; Packham, MA; Turpie, AG | 1 |
16 other study(ies) available for adenosine monophosphate and Thrombocytopenia
| Article | Year |
|---|---|
Cardiac Surgery Successfully Managed With Cangrelor in a Patient With Persistent Anti-PF4/Heparin Antibodies 8 Years After Heparin-Induced Thrombocytopenia.
Topics: Adenosine Monophosphate; Anticoagulants; Cardiac Surgical Procedures; Female; Follow-Up Studies; Forecasting; Heparin; Humans; Middle Aged; Platelet Aggregation Inhibitors; Platelet Factor 4; Postoperative Complications; Thrombocytopenia | 2019 |
Heparin-Induced Thrombocytopenia and Cardiac Surgery: Can We Do It All With Cangrelor?
Topics: Adenosine Monophosphate; Cardiopulmonary Bypass; Heparin; Humans; Kidney Failure, Chronic; Thrombocytopenia | 2019 |
In Response.
Topics: Adenosine Monophosphate; Cardiopulmonary Bypass; Heparin; Humans; Kidney Failure, Chronic; Thrombocytopenia | 2019 |
Cangrelor and Heparin for Pulmonary Thromboendarterectomy in Heparin-Induced Thrombocytopenia.
Topics: Adenosine Monophosphate; Adult; Endarterectomy; Fibrinolytic Agents; Heparin; Humans; Male; Platelet Aggregation Inhibitors; Pulmonary Embolism; Thrombocytopenia | 2020 |
Commentary: "The Enemy of My Enemy Is My Friend"-The Saga of Platelet Quiescence in Heparin-Induced Thrombocytopenia Continues.
Topics: Adenosine Monophosphate; Cardiopulmonary Bypass; Heparin; Humans; Thrombocytopenia | 2020 |
COVID-19 and remdesivir in pediatric patients: the invisible part of the iceberg.
Topics: Adenosine Monophosphate; Alanine; Child; COVID-19 Drug Treatment; Humans; Respiratory Insufficiency; SARS-CoV-2; Thrombocytopenia | 2021 |
Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention: A Pooled, Patient-Level Analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition).
Topics: Adenosine Monophosphate; Aged; Clopidogrel; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Count; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Thrombocytopenia; Time Factors; Treatment Outcome | 2018 |
Hobson's Choice: Platelet Inhibition and Thrombocytopenia.
Topics: Adenosine Monophosphate; Blood Platelets; Humans; Incidence; Percutaneous Coronary Intervention; Thrombocytopenia | 2018 |
The use of cangrelor with heparin for left ventricular assist device implantation in a patient with acute heparin-induced thrombocytopenia.
Topics: Acute Disease; Adenosine Monophosphate; Anticoagulants; Blood Coagulation Disorders; Cardiopulmonary Bypass; Drug Therapy, Combination; Heart-Assist Devices; Heparin; Humans; Intraoperative Complications; Male; Middle Aged; Platelet Aggregation Inhibitors; Prosthesis Implantation; Thrombocytopenia | 2018 |
The Use of Cangrelor and Heparin for Anticoagulation in a Patient Requiring Pulmonary Thromboendarterectomy Surgery with Suspected Heparin-Induced Thrombocytopenia.
Topics: Adenosine Monophosphate; Anticoagulants; Blood Coagulation; Drug Therapy, Combination; Endarterectomy; Heparin; Humans; Male; Platelet Aggregation Inhibitors; Thrombocytopenia; Young Adult | 2019 |
Use of Cangrelor as a Bridge to Left Ventricular Assist Device Implantation in a Patient with a Recent Drug-Eluting Stent Who Developed Acute Tirofiban-Related Thrombocytopenia.
Topics: Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Dose-Response Relationship, Drug; Drug-Eluting Stents; Heart-Assist Devices; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Thrombocytopenia; Tirofiban; Treatment Outcome; Ventricular Dysfunction, Left | 2019 |
Successful Use of Cangrelor and Heparin for Cardiopulmonary Bypass in a Patient With Heparin-Induced Thrombocytopenia and End-Stage Renal Disease: A Case Report.
Topics: Adenosine Monophosphate; Cardiopulmonary Bypass; Female; Heart Valve Prosthesis Implantation; Heparin; Humans; Intraoperative Care; Kidney Failure, Chronic; Middle Aged; Thrombocytopenia; Treatment Outcome | 2019 |
Anticoagulation in Patients With Heparin-Induced Thrombocytopenia Antibodies: New Armamentarium for an Individually Tailored Approach in Cardiac Surgery.
Topics: Adenosine Monophosphate; Anticoagulants; Cardiac Surgical Procedures; Heparin; Humans; Thrombocytopenia | 2019 |
Quantification of the Blood Platelet Reactivity in the ADP-Induced Model of Non-Lethal Pulmonary Thromboembolism in Mice with the Use of Laser Doppler Flowmetry.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Animals; Area Under Curve; Blood Platelets; Eptifibatide; Intravital Microscopy; Laser-Doppler Flowmetry; Lung; Male; Mesentery; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pulmonary Embolism; Thrombocytopenia | 2016 |
Thrombocytopenia, macrothrombocytopathia, nephritis and deafness.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adult; Blood Platelet Disorders; Blood Platelets; Cell Survival; Collagen; Cytoplasmic Granules; Deafness; Female; Humans; Kidney; Male; Middle Aged; Nephritis; Pedigree; Platelet Factor 3; Syndrome; Thrombin; Thrombocytopenia | 1976 |
Effect of Newcastle disease virus on human or rabbit platelets. Aggregation and loss of constituents.
Topics: Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Animals; Blood Platelets; Chromatography; Creatine Kinase; Cytoplasmic Granules; Edetic Acid; Hemagglutination, Viral; Humans; L-Lactate Dehydrogenase; Methods; Newcastle disease virus; Phenylbutazone; Phosphocreatine; Phosphorus Isotopes; Platelet Adhesiveness; Prostaglandins; Rabbits; Serotonin; Sulfinpyrazone; Swine; Thrombocytopenia; Time Factors | 1973 |